Bloom Energy's Record Quarter Collides With a Wall of Short-Seller Skepticism
Published on 08/02/2026 at 14:13 | Redaktion boerse-global.de
The fuel-cell maker has never posted numbers like these. Its share price, however, tells a far more complicated story — one shaped as much by bearish bets and supply-chain accusations as by the company's own operational turnaround.
Bloom Energy closed Friday at €178.80, down 0.45 percent on the day yet still up 9.83 percent over the past seven sessions. The weekly gain reflects the market's initial enthusiasm for a second-quarter report that smashed expectations, but the stock remains 42.04 percent below its 52-week high of €308.50, reached in late June. That gap between fundamental progress and share-price performance has turned this name into one of the most hotly contested battlegrounds in the clean-energy complex.
The Numbers Behind the Narrative
The July 28 earnings release marked a genuine inflection point. Revenue surged 165.5 percent year over year to a record $1.07 billion — the first time the company has ever crossed the billion-dollar quarterly threshold. Adjusted earnings per share came in at $0.78, while net income reached $196.3 million against a loss in the year-ago period. Operating cash flow climbed to $226.4 million.
Management responded by lifting full-year 2026 guidance for the second time, now targeting revenue of $3.9 billion to $4.2 billion, up from a prior range of $3.4 billion to $3.8 billion. The earnings outlook also improved, with adjusted EPS now expected between $2.55 and $2.85.
Should investors sell immediately? Or is it worth buying Bloom Energy?
The stock jumped roughly 12 percent on the news. Yet the rally has done little to close the distance to those June highs, and the reasons extend well beyond the income statement.
A Supply-Chain Attack and a Fresh Short Position
Hunterbrook Media published an investigation alleging Bloom Energy's heavy reliance on Chinese-sourced scandium could jeopardize its stated goal of five gigawatts in annual production capacity. The company fired back, calling the report false and misleading, pointing to its audited financials and explicitly rejecting the claims about its scandium oxide supply chain.
The bearish chorus has grown louder. Crossroads Capital has disclosed a short position, anticipating a downward correction. With no independent adjudication of the supply-chain dispute yet, the situation remains a standoff — assertion against assertion.
The Bull Case: Time-to-Power Wins
Optimists argue the fundamentals have fundamentally shifted. Bloom's solid-oxide fuel cells can be installed in under two months, a fraction of the multi-year wait many data centers face for grid connections. That "time-to-power" advantage has become the company's central selling point as hyperscalers scramble to secure electricity for AI infrastructure.
Three developments underpin this thesis. The Brookfield partnership has expanded into a $25 billion credit facility designed to accelerate energy delivery for AI factories. The Oracle collaboration calls for up to 2.8 gigawatts of capacity for the cloud giant's AI infrastructure. And industry reports suggest a third of new data center campuses could eventually exceed one gigawatt each — facilities that increasingly demand on-site, grid-independent power generation.
The analyst community reflects this optimism, albeit cautiously. Nine buy ratings stand against ten holds, yielding a moderate buy consensus. Mizuho upgraded the stock to "Outperform" following the recent pullback, and RBC Capital remains bullish, advising investors to use weakness as an entry point. The average price target sits at €237.08, implying roughly 32.6 percent upside from Friday's close — though still well below the June peak.
The Bear Case: Concentration Risk and Delays
Skeptics focus on the flip side of that concentrated order book. Potential projects in Texas and Spain are encouraging, but the flagship Oracle and AEP developments have slipped significantly, raising questions about whether estimates for 2027 and 2028 are achievable.
Bloom Energy at a turning point? This analysis reveals what investors need to know now.
Valuation concerns also linger. TD Cowen argues the stock is already fully priced given AI-driven volatility and a shifting investor base; by price-to-book metrics, Bloom ranks among the most expensive names in the market. The technical picture offers little clarity either way — the 14-day RSI sits at a neutral 44.4, while the annualized 30-day volatility is an eye-watering 141.44 percent, leaving the stock vulnerable to sharp moves in either direction on any headline.
The Week Ahead: Macro Takes Center Stage
For the coming days, the company's own story may take a backseat to the broader economy. The ISM manufacturing purchasing managers' index lands Monday, August 3, followed by the U.S. jobs report on Friday, August 7. Economists expect roughly 85,000 new positions — moderate by recent standards, but for a stock with this volatility profile, macro data can easily outweigh operational fundamentals in the short term.
The stock trades 19.78 percent above its 200-day moving average of €149.27, suggesting the long-term uptrend remains intact despite the correction. Over twelve months, shares have gained 449.73 percent. The technical damage from the June peak, however, will take time to repair.
The central question for investors remains one of execution: Can Bloom convert its swelling backlog into cash-generating revenue at the pace of the most recent quarter? If so, the path back to the €237.08 consensus target — and potentially toward the €308.50 high — stays open. If the Oracle or AEP projects slip further, or the scandium dispute escalates beyond press-release exchanges, a retracement toward the 200-day average becomes the more likely scenario. Until the next earnings report validates the revised guidance, expect every short-seller analysis and project-timeline update to move this stock.
Ad
Bloom Energy Stock: New Analysis - 2 August
Fresh Bloom Energy information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
